Innoviva Inc Revenue per Employee (INVA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Innoviva Inc   (NASDAQ: INVA)
 

Innoviva Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 5.55% in the third quarter 2026, year on year to cumulative value of $426 million, Innoviva Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,680,572. The productivity of Innoviva Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 22 other companies have achieved higher revenue per employee. While Innoviva Inc 's total ranking has deteriorated compared to the previous quarter from 243 to 347. Innoviva Inc has 159 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INVA Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 5.55 % 28.39 % 11.71 % 21.66 % -5.55 %
Sales per Employee (TTM) $ 2,680,572 2,645,472 2,479,151 2,419,289 2,296,478
INVA's Total Ranking # 347 # 243 # 856 # 1106 #
Seq. Revenue Change -11.26 % 31.66 % -17.17 % 9.08 % 7.94 %

INVA Company Profile >> Back to INVA Efficiency Comparisons >> Compare INVA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 15
Healthcare Sector # 23
Overall Market # 347

Revenue per Employee Statistics
High Average Low
$ 2,645,472 $ 1,441,556 $ 18,937
(Jun 30 2026)   (Jun 30 2014)



Financial Statements
Innoviva Inc 's Revenue MRQ $ 106 Millions Visit INVA's Income Statement
Innoviva Inc 's Revenues TTM $ 426 Millions Visit INVA's aggregate revenue growth
What are INVA's Sales? Visit INVA's Sales by Segment




Other Ratios
Innoviva Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
INVA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for INVA's Competitors
Revenue per Employee for INVA's Suppliers
Revenue per Employee for INVA's Customers

You may also want to know
INVA's Sales Growth Rates INVA's Pe Price to earnings ratio INVA's Receivables Turnover Ratio INVA's Stock Quote
INVA's Net Income Growth Rates INVA's Ps Price to Sales ratio INVA's Sales per Employee INVA's Asset Turnover Ratio
INVA's Net Margin INVA's Pb Price to Book ratio INVA's Financial Strength Ratios INVA's Dividend Payout Ratio
Date modified: 2026-11-08T13:39:40+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Halozyme Therapeutics Inc   4,261,106.38 $ 1,802.448  Million 423 
Ironwood Pharmaceuticals inc   4,002,960.00 $ 400.296  Million 100 
Community Health Systems Inc   3,759,032.26 $ 11,653.000  Million 3,100 
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Amgen Inc   2,992,538.46 $ 38,903.000  Million 13,000 
Liquidia Corporation  2,879,004.63 $ 621.865  Million 216 
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Sarepta Therapeutics Inc   2,342,920.96 $ 1,956.339  Million 835 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Madrigal Pharmaceuticals Inc   1,560,590.16 $ 1,427.940  Million 915 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Acadia Pharmaceuticals Inc   1,506,642.86 $ 1,202.301  Million 798 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.